Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px
Document › Details

GeneWerk GmbH. (11/29/16). "Press Release: GenoSafe and GeneWerk Bundle Their Strengths. Both Companies Work Together in the Field of Gene and Cell Therapies".

Organisations Organisation GeneWerk GmbH
  Organisation 2 GenoSafe S.A.S.
Products Product contract research (drugs)
  Product 2 gene therapy
Index term Index term GeneWerk–GenoSafe: gene/cell therapy services, 201611– collab framwork agreem to offer combined research services
Persons Person Zuliani, Vincent (GenoSafe 201611 Business Development Director)
  Person 2 Schmidt, Manfred (GeneWerk GmbH 201709 Managing Director)
     


GenoSafe and GeneWerk announced a collaborative framework agreement. Both companies will work together within the field of development of chemical, biotechnological and biological products. The aim is to complement the expertise of the partner to optimize response to client requests for expert evaluations.

“We are very pleased to announce this active collaboration with GeneWerk. In the booming gene and cell therapy field, both companies will bring their respective expertise to meet the increasing demands from customers and regulatory authorities,” said Vincent Zuliani, Business Development Director of GenoSafe.

“GeneWerk feels honored to bring its expertise into this exciting multidisciplinary partnership. Together we can efficiently help our customers in evaluating their innovative concepts to clinical translation,” said Dr. Manfred Schmidt, CEO of GeneWerk.


GenoSafe SAS is a Contract Research 0rganization which specializes in evaluating the quality, safety and efficacy of innovative biotherapeutic products. The company assists clients with customized services all along the development of their product, from the proof of concept through to market launch. contact@genosafe.com


GeneWerk GmbH provides unique worldwide experience in assessing vector safety and efficacy in gene therapy and immune repertoire studies, bioinformatics, Next Generation Sequencing and associated regulatory demands. contact@genewerk.de

   
Record changed: 2017-10-02

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px